Clinical Trial Update: A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa) [Phase 1]

View source ↗

Summary

A Phase 1 study update assessing the tolerability of the oral levodopa/carbidopa combination (Sinemet) in healthy subjects; the trial is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SINEMET (carbidopa and levodopa)

Snippet

Sponsor: NeuroDerm Ltd. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED